US Stock MarketDetailed Quotes

Altamira Therapeutics Ltd (CYTOF)

Watchlist
  • 0.0501
  • 0.00000.00%
15min DelayClose Jul 24 15:51 ET
286.35KMarket Cap-0.04P/E (TTM)

Altamira Therapeutics Ltd (CYTOF) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2018/Q4
2018/Q3
2018/Q2
2018/Q1
2017/Q4
2017/Q3
2017/Q2
2017/Q1
2016/Q4
2016/Q3
2016/Q2
2016/Q1
2015/Q4
2015/Q3
2015/Q2
2015/Q1
2014/Q4
2014/Q3
2014/Q2
2014/Q1
Total Operating Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating Expense
-88.44%646.35K
-48.76%2.92M
-49.96%3.12M
-39.03%4.51M
+13.63%5.59M
-26.94%5.70M
-32.15%6.24M
-2.96%7.40M
-23.40%4.92M
+5.14%7.81M
-12.52%9.19M
+3.10%7.63M
+54.05%6.43M
+24.22%7.42M
+85.56%10.51M
+12.02%7.40M
+5.66%4.17M
+19.69%5.98M
+9.57%5.66M
+179.80%6.61M
Selling and Admin Expenses
-62.25%413.75K
-13.02%1.19M
-14.84%1.10M
+0.16%1.43M
+7.13%1.10M
+10.62%1.37M
-26.56%1.29M
+12.52%1.42M
+2.61%1.02M
-9.27%1.24M
+66.40%1.76M
+31.77%1.27M
+1089.50%997.09K
+30.21%1.37M
+11.59%1.06M
-50.13%960.98K
-127.71%-100.77K
+207.61%1.05M
+93.49%948.34K
+577.54%1.93M
-General & Admin Expense
-62.25%413.75K
-13.02%1.19M
-14.84%1.10M
+0.16%1.43M
+7.13%1.10M
+10.62%1.37M
-26.56%1.29M
+12.52%1.42M
+2.61%1.02M
-9.27%1.24M
+66.40%1.76M
+31.77%1.27M
+1089.50%997.09K
+30.21%1.37M
+11.59%1.06M
-50.13%960.98K
-127.71%-100.77K
+207.61%1.05M
+93.49%948.34K
+577.54%1.93M
Research & Development
-99.69%13.50K
-60.07%1.73M
-59.15%2.02M
-48.37%3.09M
+14.01%4.41M
-34.04%4.33M
-33.47%4.94M
-6.04%5.98M
-27.95%3.87M
+8.39%6.57M
-21.36%7.43M
-1.17%6.36M
+27.83%5.37M
+22.94%6.06M
+100.44%9.45M
+37.62%6.44M
+18.97%4.20M
+5.91%4.93M
+0.77%4.71M
+125.31%4.68M
Operating Profit
+88.44%-646.35K
+48.76%-2.92M
+49.96%-3.12M
+39.03%-4.51M
-13.63%-5.59M
+26.94%-5.70M
+32.15%-6.24M
+2.96%-7.40M
+23.40%-4.92M
-5.14%-7.81M
+12.52%-9.19M
-3.10%-7.63M
-54.05%-6.43M
-24.22%-7.42M
-85.56%-10.51M
-12.02%-7.40M
-5.66%-4.17M
-19.69%-5.98M
-9.57%-5.66M
-179.80%-6.61M
Net Non-Operating Interest Income (Expense)
+77.88%-89.18K
+70.14%-125.38K
-22.82%-508.39K
+6.16%-365.92K
-9.31%-403.09K
-5.00%-419.82K
-3276.37%-413.92K
-4722.99%-389.93K
-3311.25%-368.74K
-3547.51%-399.82K
+352.08%13.03K
+172.61%8.43K
-24.33%11.48K
+130.86%11.60K
-95.31%2.88K
+264.71%3.09K
-92.77%15.17K
+102.20%5.02K
+121.02%61.46K
-113.19%-1.88K
Non-Operating Interest Income
-100.00%0.00
-100.00%0.00
----
-100.00%0.00
-99.82%37.65
-57.38%7.99K
-2.86%15.15K
+177.33%31.28K
+55.61%20.49K
+41.48%18.75K
+177.30%15.60K
+115.74%11.28K
-12.04%13.17K
+109.28%13.25K
-92.98%5.62K
--5.23K
--14.97K
--6.33K
+178.98%80.08K
----
Non-Operating Interest Expense
-77.88%89.18K
-70.69%125.38K
+18.49%508.39K
-13.13%365.92K
+3.57%403.13K
+2.21%427.81K
+16621.21%429.07K
+14708.70%421.21K
+23025.04%389.23K
+25184.52%418.57K
-6.42%2.57K
+33.29%2.84K
+917.05%1.68K
+26.47%1.66K
-85.27%2.74K
--2.13K
---206.00
--1.31K
+1978.25%18.62K
----
Total Other Finance Costs
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--1.88K
Other Income (Expense)
-317.62%-2.80M
+102.00%1.10K
-45.47%533.30K
+597.56%3.04M
+9.82%1.28M
-246.57%-55.37K
+71.45%978.09K
+61.83%-610.95K
-9.86%1.17M
-98.16%37.78K
+142.96%570.48K
-73.02%-1.60M
+83.24%1.30M
-16.01%2.05M
---1.33M
---925.19K
--708.33K
--2.44M
----
----
Gain on Sale of Security
-253.77%-2.80M
+302.25%111.98K
-35.48%631.08K
+3309.00%3.37M
+55.52%1.82M
-246.57%-55.37K
+71.45%978.09K
+93.44%-104.98K
-9.86%1.17M
-98.16%37.78K
+142.96%570.48K
-73.02%-1.60M
-15.72%1.30M
-16.01%2.05M
---1.33M
---925.19K
--1.54M
--2.44M
----
----
Special Income (Charges)
+100.32%1.72K
---110.88K
---97.78K
+34.97%-329.04K
---534.67K
--0.00
----
---505.97K
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
-Less:Restructuring and Mergern & Acquisition
-100.32%-1.72K
--110.88K
--97.78K
-34.97%329.04K
--534.67K
--0.00
----
--505.97K
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
Pretax Profit
+25.05%-3.53M
+50.69%-3.05M
+45.42%-3.10M
+78.11%-1.84M
-14.33%-4.71M
+24.37%-6.18M
+34.10%-5.67M
+8.86%-8.40M
+19.45%-4.12M
-52.25%-8.17M
+27.25%-8.61M
-10.82%-9.22M
-48.40%-5.12M
-51.82%-5.36M
-111.26%-11.83M
-25.94%-8.32M
+10.58%-3.45M
+32.32%-3.53M
-8.97%-5.60M
-181.57%-6.61M
Tax
+2647.28%191.40K
-5.80%-8.89K
-2.04%-8.75K
-11.78%-9.15K
+105.42%6.97K
---8.40K
---8.57K
---8.19K
---128.63K
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
----
----
----
----
Net Profit
+21.10%-3.72M
+50.77%-3.04M
+45.49%-3.09M
+78.20%-1.83M
-18.18%-4.72M
+24.47%-6.17M
+34.20%-5.66M
+8.95%-8.40M
+21.96%-3.99M
-52.25%-8.17M
+27.25%-8.61M
-10.82%-9.22M
-48.40%-5.12M
-51.82%-5.36M
-111.26%-11.83M
-25.94%-8.32M
+17.91%-3.45M
+32.32%-3.53M
-8.97%-5.60M
-181.57%-6.61M
Profit from Continuing Operations
+21.10%-3.72M
+50.77%-3.04M
+45.49%-3.09M
+78.20%-1.83M
-18.18%-4.72M
+24.47%-6.17M
+34.20%-5.66M
+8.95%-8.40M
+21.96%-3.99M
-52.25%-8.17M
+27.25%-8.61M
-10.82%-9.22M
-48.40%-5.12M
-51.82%-5.36M
-111.26%-11.83M
-25.94%-8.32M
+17.91%-3.45M
+32.32%-3.53M
-8.97%-5.60M
-181.57%-6.61M
Net Income to Parent Company
+21.10%-3.72M
+50.77%-3.04M
+45.49%-3.09M
+78.20%-1.83M
-18.18%-4.72M
+24.47%-6.17M
+34.20%-5.66M
+8.95%-8.40M
+21.96%-3.99M
-52.25%-8.17M
+27.25%-8.61M
-10.82%-9.22M
-48.40%-5.12M
-51.82%-5.36M
-111.26%-11.83M
-25.94%-8.32M
+17.91%-3.45M
+32.32%-3.53M
-8.97%-5.60M
-181.57%-6.61M
Net Income to Common Stockholders
+21.10%-3.72M
+50.77%-3.04M
+45.49%-3.09M
+78.20%-1.83M
-18.18%-4.72M
+24.47%-6.17M
+34.20%-5.66M
+8.95%-8.40M
+21.96%-3.99M
-52.25%-8.17M
+27.25%-8.61M
-10.82%-9.22M
-48.40%-5.12M
-51.82%-5.36M
-111.26%-11.83M
-25.94%-8.32M
+17.91%-3.45M
+32.32%-3.53M
-8.97%-5.60M
-181.57%-6.61M
Basic EPS
+88.13%-975.07
+89.75%-1.14K
+60.48%-4.04K
+84.19%-2.40K
+11.76%-8.21K
+41.51%-11.14K
+49.05%-10.22K
+29.49%-15.15K
+22.15%-9.31K
-51.89%-19.04K
+27.42%-20.06K
+6.49%-21.49K
-25.51%-11.95K
-28.05%-12.53K
-58.44%-27.64K
-11.68%-22.99K
+27.21%-9.52K
+39.82%-9.79K
-8.97%-17.45K
-181.57%-20.58K
Diluted EPS
+88.13%-975.07
+89.78%-1.14K
+60.48%-4.04K
+85.36%-2.52K
+11.76%-8.21K
+41.38%-11.16K
+49.93%-10.22K
+20.24%-17.19K
+22.15%-9.31K
-51.92%-19.04K
+30.48%-20.41K
+6.89%-21.55K
+13.08%-11.95K
-6.44%-12.53K
-68.32%-29.37K
-12.46%-23.15K
-5.11%-13.75K
+27.60%-11.78K
-8.97%-17.45K
-181.57%-20.58K
Deadline
Dec 31, 2018
Sep 30, 2018
Jun 30, 2018
Mar 31, 2018
Dec 31, 2017
Sep 30, 2017
Jun 30, 2017
Mar 31, 2017
Dec 31, 2016
Sep 30, 2016
Jun 30, 2016
Mar 31, 2016
Dec 31, 2015
Sep 30, 2015
Jun 30, 2015
Mar 31, 2015
Dec 31, 2014
Sep 30, 2014
Jun 30, 2014
Mar 31, 2014
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
2018/Q42018/Q32018/Q22018/Q12017/Q42017/Q32017/Q22017/Q12016/Q42016/Q32016/Q22016/Q12015/Q42015/Q32015/Q22015/Q12014/Q42014/Q32014/Q22014/Q1
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of de-escalation in U.S.-Iran military tensions have emerged, pushing international oil prices lower. Trump ordered the U.S. military Show More